Showing results (161-170 of 513) with videos related to
Sort By:
Pageof 52
Oncotarget|February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaBo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.Cancer Research and Treatment|May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung CancerJiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinomaJiyun Lee, Hyun Ae Jung, Youjin Kim, et al.Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancerHyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.Computer Methods and Programs in Biomedicine|July 3, 2025
Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predict outcomes of immunotherapy in non-small cell lung cancerDong Young Jeong, Cheol Yong Joe, Sang Min Lee, et al.Head & Neck|April 3, 2009
Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinomaKyubo Kim, Hong-Gyun Wu, Hak Jae Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 12, 2020
Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational StatusJiyun Lee, Yoon La Choi, Joungho Han, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial TumorsHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancerSehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.Cancer Research and Treatment|March 13, 2015
Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer PatientsSeung-Hoon Beom, Dong-Wan Kim, Sung Hoon Sim, et al.Pageof 52